Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 129, 2023 - Issue 5
1,102
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Asprosin, a novel glucogenic adipokine: a potential therapeutic implication in diabetes mellitus

, ORCID Icon, , , , , , , ORCID Icon & ORCID Icon show all
Pages 1038-1044 | Received 17 Jan 2021, Accepted 18 Feb 2021, Published online: 04 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jia-Xue Cheng & Ke Yu. (2022) New Discovered Adipokines Associated with the Pathogenesis of Obesity and Type 2 Diabetes. Diabetes, Metabolic Syndrome and Obesity 15, pages 2381-2389.
Read now

Articles from other publishers (8)

Muhammed Adam, Sibel Ozcan, Semih Dalkilic, Nalan Kaya Tektemur, Suat Tekin, Batuhan Bilgin, Munevver Gizem Hekim, Ferah Bulut, Muhammed Mirac Kelestemur, Sinan Canpolat & Mete Ozcan. (2023) Modulation of Neuronal Damage in DRG by Asprosin in a High-Glucose Environment and Its Impact on miRNA181-a Expression in Diabetic DRG. Neurotoxicity Research 42:1.
Crossref
Selcen ÇAKIR & Yunus DEMİRTAŞ. (2023) Effects of high calorie dietary nutrition and exercise on energy metabolism parameters in obese Wistar albino ratsObez Wistar albino sıçanlarda yüksek kalorili diyet ve egzersizin enerji metabolizma parametreleri üzerindeki etkileri. Cukurova Medical Journal 48:4, pages 1388-1395.
Crossref
Mesut YurSibel ÖzcanNilgün YıldırımMehmet R. ÖzdedeMete Özcan. (2023) Elevated Asprosin Levels in Breast Cancer: Insights from a Comparative Study. Journal of Women's Health.
Crossref
Selcen ÇAKIR. (2023) The Effect of Royal Jelly on Irisin in Experimentally Diabetic Rats. Sakarya University Journal of Science 27:4, pages 912-919.
Crossref
Xiao-Li Wang, Jing-Xiao Wang, Jun-Liu Chen, Wen-Yuan Hao, Wen-Zhou Xu, Zhi-Qin Xu, Yu-Tong Jiang, Pei-Qi Luo, Qi Chen, Yue-Hua Li, Guo-Qing Zhu & Xiu-Zhen Li. (2022) Asprosin in the Paraventricular Nucleus Induces Sympathetic Activation and Pressor Responses via cAMP-Dependent ROS Production. International Journal of Molecular Sciences 23:20, pages 12595.
Crossref
Lifei Liu, Yuhao Liu, Mei Huang, Miao Zhang, Chenyu Zhu, Xi Chen, Samuel Bennett, Jiake Xu & Jun Zou. (2022) The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases. Frontiers in Physiology 13.
Crossref
Sibel Ozcan, Muhammed Mirac Kelestemur, Munevver Gizem Hekim, Ozgur Bulmus, Ferah Bulut, Batuhan Bilgin, Sinan Canpolat & Mete Ozcan. (2022) Asprosin, a novel therapeutic candidate for painful neuropathy: an experimental study in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 395:3, pages 325-335.
Crossref
Ila Mishra, Clemens Duerrschmid, Zhiqiang Ku, Yang He, Wei Xie, Elizabeth Sabath Silva, Jennifer Hoffman, Wei Xin, Ningyan Zhang, Yong Xu, Zhiqiang An & Atul R Chopra. (2021) Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. eLife 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.